Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients.

Alaskan Native American Indian Black Hispanic Pacific Islander Washington State coronavirus coronavirus disease 2019 ethnic disparity fetus infection rate pregnancy severe acute respiratory syndrome coronavirus 2

Journal

American journal of obstetrics and gynecology
ISSN: 1097-6868
Titre abrégé: Am J Obstet Gynecol
Pays: United States
ID NLM: 0370476

Informations de publication

Date de publication:
07 2021
Historique:
received: 03 01 2021
revised: 08 02 2021
accepted: 09 02 2021
pubmed: 20 2 2021
medline: 16 7 2021
entrez: 19 2 2021
Statut: ppublish

Résumé

During the early months of the coronavirus disease 2019 pandemic, risks associated with severe acute respiratory syndrome coronavirus 2 in pregnancy were uncertain. Pregnant patients can serve as a model for the success of clinical and public health responses during public health emergencies as they are typically in frequent contact with the medical system. Population-based estimates of severe acute respiratory syndrome coronavirus 2 infections in pregnancy are unknown because of incomplete ascertainment of pregnancy status or inclusion of only single centers or hospitalized cases. Whether pregnant women were protected by the public health response or through their interactions with obstetrical providers in the early months of pandemic is not clearly understood. This study aimed to estimate the severe acute respiratory syndrome coronavirus 2 infection rate in pregnancy and to examine the disparities by race and ethnicity and English language proficiency in Washington State. Pregnant patients with a polymerase chain reaction-confirmed severe acute respiratory syndrome coronavirus 2 infection diagnosed between March 1, 2020, and June 30, 2020 were identified within 35 hospitals and clinics, capturing 61% of annual deliveries in Washington State. Infection rates in pregnancy were estimated overall and by Washington State Accountable Community of Health region and cross-sectionally compared with severe acute respiratory syndrome coronavirus 2 infection rates in similarly aged adults in Washington State. Race and ethnicity and language used for medical care of pregnant patients were compared with recent data from Washington State. A total of 240 pregnant patients with severe acute respiratory syndrome coronavirus 2 infections were identified during the study period with 70.7% from minority racial and ethnic groups. The principal findings in our study were as follows: (1) the severe acute respiratory syndrome coronavirus 2 infection rate was 13.9 per 1000 deliveries in pregnant patients (95% confidence interval, 8.3-23.2) compared with 7.3 per 1000 (95% confidence interval, 7.2-7.4) in adults aged 20 to 39 years in Washington State (rate ratio, 1.7; 95% confidence interval, 1.3-2.3); (2) the severe acute respiratory syndrome coronavirus 2 infection rate reduced to 11.3 per 1000 deliveries (95% confidence interval, 6.3-20.3) when excluding 45 cases of severe acute respiratory syndrome coronavirus disease 2 detected through asymptomatic screening (rate ratio, 1.3; 95% confidence interval, 0.96-1.9); (3) the proportion of pregnant patients in non-White racial and ethnic groups with severe acute respiratory syndrome coronavirus disease 2 infection was 2- to 4-fold higher than the race and ethnicity distribution of women in Washington State who delivered live births in 2018; and (4) the proportion of pregnant patients with severe acute respiratory syndrome coronavirus 2 infection receiving medical care in a non-English language was higher than estimates of pregnant patients receiving care with limited English proficiency in Washington State (30.4% vs 7.6%). The severe acute respiratory syndrome coronavirus 2 infection rate in pregnant people was 70% higher than similarly aged adults in Washington State, which could not be completely explained by universal screening at delivery. Pregnant patients from nearly all racial and ethnic minority groups and patients receiving medical care in a non-English language were overrepresented. Pregnant women were not protected from severe acute respiratory syndrome coronavirus 2 infection in the early months of the pandemic. Moreover, the greatest burden of infections occurred in nearly all racial and ethnic minority groups. These data coupled with a broader recognition that pregnancy is a risk factor for severe illness and maternal mortality strongly suggested that pregnant people should be broadly prioritized for coronavirus disease 2019 vaccine allocation in the United States similar to some states.

Sections du résumé

BACKGROUND
During the early months of the coronavirus disease 2019 pandemic, risks associated with severe acute respiratory syndrome coronavirus 2 in pregnancy were uncertain. Pregnant patients can serve as a model for the success of clinical and public health responses during public health emergencies as they are typically in frequent contact with the medical system. Population-based estimates of severe acute respiratory syndrome coronavirus 2 infections in pregnancy are unknown because of incomplete ascertainment of pregnancy status or inclusion of only single centers or hospitalized cases. Whether pregnant women were protected by the public health response or through their interactions with obstetrical providers in the early months of pandemic is not clearly understood.
OBJECTIVE
This study aimed to estimate the severe acute respiratory syndrome coronavirus 2 infection rate in pregnancy and to examine the disparities by race and ethnicity and English language proficiency in Washington State.
STUDY DESIGN
Pregnant patients with a polymerase chain reaction-confirmed severe acute respiratory syndrome coronavirus 2 infection diagnosed between March 1, 2020, and June 30, 2020 were identified within 35 hospitals and clinics, capturing 61% of annual deliveries in Washington State. Infection rates in pregnancy were estimated overall and by Washington State Accountable Community of Health region and cross-sectionally compared with severe acute respiratory syndrome coronavirus 2 infection rates in similarly aged adults in Washington State. Race and ethnicity and language used for medical care of pregnant patients were compared with recent data from Washington State.
RESULTS
A total of 240 pregnant patients with severe acute respiratory syndrome coronavirus 2 infections were identified during the study period with 70.7% from minority racial and ethnic groups. The principal findings in our study were as follows: (1) the severe acute respiratory syndrome coronavirus 2 infection rate was 13.9 per 1000 deliveries in pregnant patients (95% confidence interval, 8.3-23.2) compared with 7.3 per 1000 (95% confidence interval, 7.2-7.4) in adults aged 20 to 39 years in Washington State (rate ratio, 1.7; 95% confidence interval, 1.3-2.3); (2) the severe acute respiratory syndrome coronavirus 2 infection rate reduced to 11.3 per 1000 deliveries (95% confidence interval, 6.3-20.3) when excluding 45 cases of severe acute respiratory syndrome coronavirus disease 2 detected through asymptomatic screening (rate ratio, 1.3; 95% confidence interval, 0.96-1.9); (3) the proportion of pregnant patients in non-White racial and ethnic groups with severe acute respiratory syndrome coronavirus disease 2 infection was 2- to 4-fold higher than the race and ethnicity distribution of women in Washington State who delivered live births in 2018; and (4) the proportion of pregnant patients with severe acute respiratory syndrome coronavirus 2 infection receiving medical care in a non-English language was higher than estimates of pregnant patients receiving care with limited English proficiency in Washington State (30.4% vs 7.6%).
CONCLUSION
The severe acute respiratory syndrome coronavirus 2 infection rate in pregnant people was 70% higher than similarly aged adults in Washington State, which could not be completely explained by universal screening at delivery. Pregnant patients from nearly all racial and ethnic minority groups and patients receiving medical care in a non-English language were overrepresented. Pregnant women were not protected from severe acute respiratory syndrome coronavirus 2 infection in the early months of the pandemic. Moreover, the greatest burden of infections occurred in nearly all racial and ethnic minority groups. These data coupled with a broader recognition that pregnancy is a risk factor for severe illness and maternal mortality strongly suggested that pregnant people should be broadly prioritized for coronavirus disease 2019 vaccine allocation in the United States similar to some states.

Identifiants

pubmed: 33607103
pii: S0002-9378(21)00098-3
doi: 10.1016/j.ajog.2021.02.011
pmc: PMC7884918
pii:
doi:

Types de publication

Journal Article Multicenter Study Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

75.e1-75.e16

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI145890
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD098713
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007044
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI133976
Pays : United States
Organisme : NIAID NIH HHS
ID : K23 AI120793
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI144938
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI143265
Pays : United States
Organisme : NICHD NIH HHS
ID : K12 HD001264
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002319
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Erica M Lokken (EM)

Department of Global Health, University of Washington, Seattle, WA; Department of Obstetrics & Gynecology, University of Washington, Seattle, WA.

G Gray Taylor (GG)

Department of Epidemiology, University of Washington, Seattle, WA.

Emily M Huebner (EM)

School of Medicine, University of Washington, Seattle, WA.

Jeroen Vanderhoeven (J)

Swedish Maternal Fetal Specialty Center, Swedish Medical Center, Seattle, WA; Obstetrix Medical Group, Seattle, WA.

Sarah Hendrickson (S)

Yakima Valley Farm Worker's Clinic, Yakima, WA.

Brahm Coler (B)

Elson S. Floyd College of Medicine, Washington State University, Spokane, WA.

Jessica S Sheng (JS)

MultiCare Maternal Fetal Medicine, Tacoma, WA.

Christie L Walker (CL)

MultiCare Health System, Tacoma, WA.

Stephen A McCartney (SA)

Department of Obstetrics & Gynecology, University of Washington, Seattle, WA.

Nicole M Kretzer (NM)

Department of Obstetrics & Gynecology, University of Washington, Seattle, WA.

Rebecca Resnick (R)

School of Medicine, University of Washington, Seattle, WA.

Alisa Kachikis (A)

Department of Obstetrics & Gynecology, University of Washington, Seattle, WA.

Nena Barnhart (N)

Department of Obstetrics and Gynecology, PeaceHealth St. Joseph's Medical Center, Bellingham, WA.

Vera Schulte (V)

School of Medicine, University of Washington, Seattle, WA.

Brittany Bergam (B)

School of Medicine, University of Washington, Seattle, WA.

Kimberly K Ma (KK)

Department of Obstetrics & Gynecology, University of Washington, Seattle, WA.

Catherine Albright (C)

Department of Obstetrics & Gynecology, University of Washington, Seattle, WA.

Valerie Larios (V)

Yakima Valley Farm Worker's Clinic, Yakima, WA.

Lori Kelley (L)

Yakima Valley Farm Worker's Clinic, Yakima, WA.

Victoria Larios (V)

Yakima Valley Farm Worker's Clinic, Yakima, WA.

Sharilyn Emhoff (S)

Virginia Mason Memorial, Yakima, WA.

Jasmine Rah (J)

School of Medicine, University of Washington, Seattle, WA.

Kristin Retzlaff (K)

Quality Department, EvergreenHealth Medical Center, Kirkland, WA.

Chad Thomas (C)

Department of Obstetrics and Gynecology, PeaceHealth St. Joseph's Medical Center, Bellingham, WA.

Bettina W Paek (BW)

Eastside Maternal Fetal Medicine, EvergreenHealth Medical Center, Kirkland, WA; Obstetrix of Washington, Bellevue, WA.

Rita J Hsu (RJ)

Department of Obstetrics & Gynecology, University of Washington, Seattle, WA; Women's and Children's Health, Confluence Health, Wenatchee, WA.

Anne Erickson (A)

Department of Obstetrics & Gynecology, University of Washington, Seattle, WA.

Andrew Chang (A)

Yakima Valley Farm Worker's Clinic, Yakima, WA.

Timothy Mitchell (T)

Department of Obstetrics and Gynecology, Vancouver Clinic, Vancouver, WA.

Joseph K Hwang (JK)

Department of Obstetrics & Gynecology, University of Washington, Seattle, WA.

Rebecca Gourley (R)

University of Washington, Seattle, WA.

Stephen Erickson (S)

School of Medicine, University of Washington, Seattle, WA; Elson S. Floyd College of Medicine, Washington State University, Spokane, WA; Jefferson Health Care, Port Townsend, WA.

Shani Delaney (S)

Department of Obstetrics & Gynecology, University of Washington, Seattle, WA.

Carolyn R Kline (CR)

Eastside Maternal Fetal Medicine, EvergreenHealth Medical Center, Kirkland, WA; Obstetrix of Washington, Bellevue, WA.

Karen Archabald (K)

Legacy Health, Vancouver, WA.

Michela Blain (M)

Department of Medicine, University of Washington, Seattle, WA.

Sylvia M LaCourse (SM)

Department of Global Health, University of Washington, Seattle, WA; Department of Medicine, University of Washington, Seattle, WA.

Kristina M Adams Waldorf (KM)

Department of Global Health, University of Washington, Seattle, WA; Department of Obstetrics & Gynecology, University of Washington, Seattle, WA. Electronic address: adamsk@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH